[{"id":"f313db1d-9024-4857-9616-3c29020b70ae","acronym":"TNBC-MERIT","url":"https://clinicaltrials.gov/study/NCT02316457","created_at":"2021-01-18T10:58:35.982Z","updated_at":"2025-02-25T16:24:25.969Z","phase":"Phase 1","brief_title":"RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID","source_id_and_acronym":"NCT02316457 - TNBC-MERIT","lead_sponsor":"BioNTech SE","biomarkers":" HER-2 • ER • PGR","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BNT114 • IVAC_M_uID"],"overall_status":"Completed","enrollment":" Enrollment 42","initiation":"Initiation: 10/01/2016","start_date":" 10/01/2016","primary_txt":" Primary completion: 05/13/2020","primary_completion_date":" 05/13/2020","study_txt":" Completion: 05/17/2023","study_completion_date":" 05/17/2023","last_update_posted":"2023-07-19"}]